Advertisement

Search Results

Advertisement



Your search for Jacek Jassem, MD, PhD, and Rafał Dziadziuszko, MD, PhD matches 1 pages

Showing 1 - 1


lung cancer

Crizotinib in ROS1-Positive NSCLC: A Next Step Forward

Advances in the molecular characterization of non–small cell lung cancer (NSCLC) have led to the identification of molecularly defined distinct subsets of patients who derive benefit from targeted therapies. Currently, two such groups of agents have moved widely into clinical practice: epidermal...

Advertisement

Advertisement



Advertisement